374 related articles for article (PubMed ID: 21270669)
1. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
[TBL] [Abstract][Full Text] [Related]
2. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
[TBL] [Abstract][Full Text] [Related]
3. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
4. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.
Delea TE; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
J Thorac Oncol; 2006 Jul; 1(6):571-6. PubMed ID: 17409919
[TBL] [Abstract][Full Text] [Related]
5. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle metastasis from non-small cell lung cancer.
Pop D; Nadeemy AS; Venissac N; Guiraudet P; Otto J; Poudenx M; Mouroux J
J Thorac Oncol; 2009 Oct; 4(10):1236-41. PubMed ID: 19641472
[TBL] [Abstract][Full Text] [Related]
7. Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
Descourt R; Vergnenegre A; Barlesi F; Lena H; Fournel P; Falchero L; Berard H; Hureaux J; Le Caer H; Chavaillon JM; Geriniere L; Monnet I; Chouabe S; Robinet G;
J Thorac Oncol; 2011 Feb; 6(2):351-7. PubMed ID: 21164367
[TBL] [Abstract][Full Text] [Related]
8. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).
De Ruysscher D; Wanders R; van Baardwijk A; Dingemans AM; Reymen B; Houben R; Bootsma G; Pitz C; van Eijsden L; Geraedts W; Baumert BG; Lambin P
J Thorac Oncol; 2012 Oct; 7(10):1547-55. PubMed ID: 22982655
[TBL] [Abstract][Full Text] [Related]
9. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
[TBL] [Abstract][Full Text] [Related]
10. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.
Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D
J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050
[TBL] [Abstract][Full Text] [Related]
11. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.
Hoppe BS; Flampouri S; Henderson RH; Pham D; Bajwa AA; D'Agostino H; Huh SN; Li Z; Mendenhall NP; Nichols RC
Clin Lung Cancer; 2012 Sep; 13(5):352-8. PubMed ID: 22264659
[TBL] [Abstract][Full Text] [Related]
13. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
[TBL] [Abstract][Full Text] [Related]
14. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdom.
Joshi AD; Carter JA; Botteman MF; Kaura S
Clin Ther; 2011 Mar; 33(3):291-304.e8. PubMed ID: 21600384
[TBL] [Abstract][Full Text] [Related]
16. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
17. [An economic analysis of the management of bone metastases in lung cancer].
Decroisette C; Locher C; Iglesias E; Chouaid C;
Rev Mal Respir; 2006 Nov; 23(5 Pt 1):497-502. PubMed ID: 17314755
[TBL] [Abstract][Full Text] [Related]
18. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Harada H; Nishio M; Murakami H; Ohyanagi F; Kozuka T; Ishikura S; Naito T; Kaira K; Takahashi T; Horiike A; Nishimura T; Yamamoto N
Clin Lung Cancer; 2013 Jul; 14(4):440-5. PubMed ID: 23540866
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.
Nieder C; Tollåli T; Norum J; Pawinski A; Bremnes RM
Anticancer Res; 2012 Jan; 32(1):189-94. PubMed ID: 22213306
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]